PESTELL RICHARD G has a total of 14 patent applications. Its first patent ever was published in 2011. It filed its patents most often in United States, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CURIDIUM LTD, FUNDACIO HOSPITAL UNI VALL D HEBRON INST DE RECERCA and RODRIGUEZ OQUENDO ANNABELLE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | Canada | 1 | |
#7 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Medical preparations | |
#5 | Animal care | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Pestell Richard G | 14 |
#2 | Katiyar Sanjay | 1 |
#3 | Casimiro Mathew | 1 |
#4 | Jiao Xuanmao | 1 |
#5 | Popov Vladimir M | 1 |
#6 | Wu Kongming | 1 |
Publication | Filing date | Title |
---|---|---|
CN104853806A | Using modulators of CCR5 for treating cancer | |
AU2012225232A1 | Prostate cancer cell lines, gene signatures and uses thereof | |
US2013011411A1 | Methods and compositions for the diagnosis, prognosis, and treatment of cancer |